Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
Focus on gastric cancer *

Epidemiology and incidence statistics
• Animal models
• Disease mechanism and molecular targets

• Histological classification and gastric/intestinal phenotypes
• Gastric cancer predisposition
• Molecular alterations in gastric cancer
• Factors that induce molecular alterations
• Diagnosis of gastric cancers

• Diagnostic criteria for early gastric cancers and endoscopic mucosal resection
• Metastases and their diagnosis
• Treatment of gastric cancers and its recent advances

• Chemoradiotherapy and D2 surgery
• New chemotherapeutic agent
• Future challenges

* Legal Disclaimer: Chelation and Hyperbaric Therapy, Stem Cell Therapy, and other treatments and modalities mentioned or referred to in this web site are medical techniques that may or may not be considered “mainstream”. As with any medical treatment, results will vary among individuals, and there is no implication or guarantee that you will heal or achieve the same outcome as patients herein.

As with any procedure, there could be pain or other substantial risks involved. These concerns should be discussed with your health care provider prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.

THE INFORMATION IN THIS WEBSITE IS OFFERED FOR GENERAL EDUCATIONAL PURPOSES ONLY AND DOES NOT IMPLY OR GIVE MEDICAL ADVICE. No Doctor/Patient relationship shall be deemed to have arisen simply by reading the information contained on these pages, and you should consult with your personal physician/care giver regarding your medical treatment before undergoing any sort of treatment or therapy.

Published on 04-17-2008